• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌射频消融术后肝脏脂肪含量的定量分析:与肝灌注障碍的相关性

Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders.

作者信息

Shen Li-Shan, Li Quan-Xi, Luo Xiao-Wen, Tang Hui-Jun, Tang You-Jie, Tang Wen-Jie, Guo Ruo-Mi

机构信息

Department of Radiology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510635, China.

出版信息

Diagnostics (Basel). 2021 Nov 18;11(11):2137. doi: 10.3390/diagnostics11112137.

DOI:10.3390/diagnostics11112137
PMID:34829484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8625447/
Abstract

PURPOSE

To quantitatively investigate the correlation between liver fat content and hepatic perfusion disorders (HPD) after radiofrequency ablation (RFA) for liver cancer using magnetic resonance imaging (MRI)-determined proton density fat fraction (PDFF).

MATERIALS AND METHODS

A total of 150 liver cancer patients underwent liver MRI examination within one month after RFA and at four months after RFA. According to the liver fat content, they were divided into non-, mild, moderate, and severe fatty liver groups. The liver fat content and hepatic perfusion disorders were determined using PDFF images and dynamic contrast-enhanced MRI images. The relationship between the liver fat content and HPD was investigated.

RESULTS

At the first postoperative MRI examination, the proportion of patients in the nonfatty liver group with hyperperfused foci (11.11%) was significantly lower than that in the mild (30.00%), moderate (42.86%), and severe fatty liver (56.67%) groups ( < 0.05), whereas the proportions of patients with hypoperfused foci (6.67%, 7.5%, 5.71%, and 6.67%, respectively) were not significantly different among the four groups ( > 0.05). In the nonfatty liver group, the liver fat content was not correlated with hyperperfusion abnormalities or hypoperfusion abnormalities. By contrast, in the three fatty liver groups, the liver fat content was correlated with hyperperfusion abnormalities but was not correlated with hypoperfusion abnormalities. At the second postoperative MRI examination, six patients in the nonfatty liver group were diagnosed with fatty liver, including two patients with newly developed hyperperfusion abnormalities and one patient whose hypoperfusion abnormality remained the same as it was in the first postoperative MRI examination.

CONCLUSION

There was a high correlation between the liver fat content and hyperperfusion abnormalities after RFA for liver cancer. The higher the liver fat content was, the higher the was risk of hyperperfusion abnormalities. However, there was little correlation between liver fat content and hypoperfusion abnormalities, and the increase in postoperative liver fat content did not induce or alter the presence of hypoperfused foci.

摘要

目的

利用磁共振成像(MRI)测定的质子密度脂肪分数(PDFF),定量研究肝癌射频消融(RFA)后肝脏脂肪含量与肝灌注障碍(HPD)之间的相关性。

材料与方法

150例肝癌患者在RFA后1个月内及RFA后4个月接受肝脏MRI检查。根据肝脏脂肪含量,将他们分为非脂肪肝组、轻度脂肪肝组、中度脂肪肝组和重度脂肪肝组。使用PDFF图像和动态对比增强MRI图像测定肝脏脂肪含量和肝灌注障碍。研究肝脏脂肪含量与HPD之间的关系。

结果

术后首次MRI检查时,非脂肪肝组出现高灌注灶的患者比例(11.11%)显著低于轻度(30.00%)、中度(42.86%)和重度脂肪肝组(56.67%)(P<0.05),而四组中出现低灌注灶的患者比例分别为6.67%、7.5%、5.71%和6.67%,差异无统计学意义(P>0.05)。在非脂肪肝组中,肝脏脂肪含量与高灌注异常或低灌注异常均无相关性。相比之下,在三个脂肪肝组中,肝脏脂肪含量与高灌注异常相关,但与低灌注异常无关。术后第二次MRI检查时,非脂肪肝组有6例患者被诊断为脂肪肝,其中2例出现新的高灌注异常,1例低灌注异常与术后首次MRI检查时相同。

结论

肝癌RFA后肝脏脂肪含量与高灌注异常之间存在高度相关性。肝脏脂肪含量越高,发生高灌注异常的风险越高。然而,肝脏脂肪含量与低灌注异常之间几乎没有相关性,术后肝脏脂肪含量的增加并未诱导或改变低灌注灶的存在。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/8625447/ba7a46f3a33b/diagnostics-11-02137-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/8625447/411151132dd6/diagnostics-11-02137-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/8625447/b26fe3b4098f/diagnostics-11-02137-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/8625447/b922f421372e/diagnostics-11-02137-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/8625447/29f5a1d25807/diagnostics-11-02137-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/8625447/ba7a46f3a33b/diagnostics-11-02137-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/8625447/411151132dd6/diagnostics-11-02137-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/8625447/b26fe3b4098f/diagnostics-11-02137-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/8625447/b922f421372e/diagnostics-11-02137-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/8625447/29f5a1d25807/diagnostics-11-02137-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2301/8625447/ba7a46f3a33b/diagnostics-11-02137-g005.jpg

相似文献

1
Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders.肝癌射频消融术后肝脏脂肪含量的定量分析:与肝灌注障碍的相关性
Diagnostics (Basel). 2021 Nov 18;11(11):2137. doi: 10.3390/diagnostics11112137.
2
A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.磁共振成像质子密度脂肪分数和磁共振波谱测定的肝脏脂肪含量与非酒精性脂肪性肝病肝脏组织学的比较
Acta Radiol. 2016 Mar;57(3):271-8. doi: 10.1177/0284185115580488. Epub 2015 Apr 8.
3
Simultaneous quantification of hepatic MRI-PDFF and R2* in a rabbit model with nonalcoholic fatty liver disease.同时定量兔非酒精性脂肪肝模型的肝脏 MRI-PDFF 和 R2*值。
Sci China Life Sci. 2018 Sep;61(9):1107-1114. doi: 10.1007/s11427-017-9279-1. Epub 2018 Jun 20.
4
Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.磁共振成像质子密度脂肪分数作为参考标准的非酒精性脂肪性肝病肝脂肪变性的定量超声射频数据分析。
Korean J Radiol. 2021 Jul;22(7):1077-1086. doi: 10.3348/kjr.2020.1262. Epub 2021 Mar 9.
5
Quantification of Liver Fat Content With Unenhanced MDCT: Phantom and Clinical Correlation With MRI Proton Density Fat Fraction.采用平扫 MDCT 定量肝脏脂肪含量:与 MRI 质子密度脂肪分数的 phantom 及临床相关性。
AJR Am J Roentgenol. 2018 Sep;211(3):W151-W157. doi: 10.2214/AJR.17.19391. Epub 2018 Jul 17.
6
Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease.序贯质子密度脂肪分数对非酒精性脂肪性肝病肝脂肪变性定量的影响
Scand J Gastroenterol. 2014 May;49(5):617-24. doi: 10.3109/00365521.2014.894118. Epub 2014 Apr 2.
7
Validation of a motion-robust 2D sequential technique for quantification of hepatic proton density fat fraction during free breathing.验证一种运动稳健的 2D 序列技术,用于在自由呼吸期间定量肝质子密度脂肪分数。
J Magn Reson Imaging. 2018 Dec;48(6):1578-1585. doi: 10.1002/jmri.26056. Epub 2018 Apr 17.
8
Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.应用定量超声评估非酒精性脂肪性肝病患者的肝脂肪变
Radiology. 2020 Apr;295(1):106-113. doi: 10.1148/radiol.2020191152. Epub 2020 Feb 4.
9
Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.肝脂肪变性:质子密度脂肪分数磁共振成像与肝活检的定量比较。
Radiology. 2013 Jun;267(3):767-75. doi: 10.1148/radiol.13121360. Epub 2013 Feb 4.
10
Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?通过磁共振成像质子密度脂肪分数测定的可忽略不计的肝脂肪变性是否可以免除潜在肝供体的肝活检?
Liver Transpl. 2018 Apr;24(4):470-477. doi: 10.1002/lt.24965. Epub 2018 Mar 6.

本文引用的文献

1
Unveiling the unreal: Comprehensive imaging review of hepatic pseudolesions.揭示假象:肝脏假性病变的综合影像学评价。
Clin Imaging. 2021 Dec;80:439-453. doi: 10.1016/j.clinimag.2021.09.008. Epub 2021 Sep 17.
2
Quantification of penile fat infiltration using the mDIXON Quant sequence: a pilot study on the correlation with penis hardness and erectile dysfunction.使用 mDIXON Quant 序列对阴茎脂肪浸润进行定量分析:与阴茎硬度和勃起功能障碍相关性的初步研究。
Br J Radiol. 2021 Jul 1;94(1123):20201400. doi: 10.1259/bjr.20201400. Epub 2021 Jun 16.
3
Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis.
非酒精性脂肪性肝炎患者的 MRI-PDFF 和组织学应答变化:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2021 Nov;19(11):2274-2283.e5. doi: 10.1016/j.cgh.2020.08.061. Epub 2020 Aug 31.
4
Multislice Computed Tomographic Manifestation of Transient Hepatic Attenuation Difference in the Left Lobe of the Liver: A Retrospective Study.多层 CT 表现的肝脏左叶一过性肝衰减差异:一项回顾性研究。
Adv Ther. 2020 Sep;37(9):3954-3966. doi: 10.1007/s12325-020-01428-5. Epub 2020 Jul 26.
5
Liver Fat Content Measurement with Quantitative CT Validated against MRI Proton Density Fat Fraction: A Prospective Study of 400 Healthy Volunteers.定量 CT 测量肝脏脂肪含量与 MRI 质子密度脂肪分数的对照:400 名健康志愿者的前瞻性研究。
Radiology. 2020 Jan;294(1):89-97. doi: 10.1148/radiol.2019190467. Epub 2019 Nov 5.
6
Accuracy of ultrasonography in the assessment of liver fat compared with MRI.超声检查评估肝脏脂肪与 MRI 的准确性比较。
Clin Radiol. 2019 Jul;74(7):539-546. doi: 10.1016/j.crad.2019.02.014. Epub 2019 Apr 5.
7
Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis.磁共振质子密度脂肪分数成像对非酒精性脂肪性肝病患者肝脂肪变的诊断价值:一项荟萃分析。
Eur Radiol. 2019 Jul;29(7):3564-3573. doi: 10.1007/s00330-019-06072-4. Epub 2019 Mar 21.
8
Quantification of fat deposition in the testis and epididymis using mDIXON Quant sequence: correlation with age and ejaculation.使用 mDIXON Quant 序列对睾丸和附睾脂肪沉积进行定量:与年龄和射精的相关性。
Abdom Radiol (NY). 2019 Apr;44(4):1528-1534. doi: 10.1007/s00261-018-1826-3.
9
Quantification of Liver Fat Content With Unenhanced MDCT: Phantom and Clinical Correlation With MRI Proton Density Fat Fraction.采用平扫 MDCT 定量肝脏脂肪含量:与 MRI 质子密度脂肪分数的 phantom 及临床相关性。
AJR Am J Roentgenol. 2018 Sep;211(3):W151-W157. doi: 10.2214/AJR.17.19391. Epub 2018 Jul 17.
10
Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中肝脏脂肪含量的无创定量检测方法
J Clin Transl Hepatol. 2018 Jun 28;6(2):217-221. doi: 10.14218/JCTH.2018.00021. Epub 2018 Jun 22.